6-32638949-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_002122.5(HLA-DQA1):c.82+1409A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0010 ( 12 hom., cov: 18)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
HLA-DQA1
NM_002122.5 intron
NM_002122.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0510
Genes affected
HLA-DQA1 (HGNC:4942): (major histocompatibility complex, class II, DQ alpha 1) HLA-DQA1 belongs to the HLA class II alpha chain paralogues. The class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B Lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa. It is encoded by 5 exons; exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-32638949-A-G is Benign according to our data. Variant chr6-32638949-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2656469.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HLA-DQA1 | NM_002122.5 | c.82+1409A>G | intron_variant | ENST00000343139.11 | NP_002113.2 | |||
HLA-DQA1 | XM_006715079.5 | c.82+1409A>G | intron_variant | XP_006715142.1 | ||||
HLA-DQA1-AS1 | XR_007059544.1 | n.1214T>C | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HLA-DQA1 | ENST00000343139.11 | c.82+1409A>G | intron_variant | 6 | NM_002122.5 | ENSP00000339398.5 |
Frequencies
GnomAD3 genomes AF: 0.000998 AC: 118AN: 118232Hom.: 12 Cov.: 18
GnomAD3 genomes
AF:
AC:
118
AN:
118232
Hom.:
Cov.:
18
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000310 AC: 3AN: 96792Hom.: 0 AF XY: 0.0000376 AC XY: 2AN XY: 53128
GnomAD3 exomes
AF:
AC:
3
AN:
96792
Hom.:
AF XY:
AC XY:
2
AN XY:
53128
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000165 AC: 4AN: 241736Hom.: 0 Cov.: 0 AF XY: 0.00000722 AC XY: 1AN XY: 138594
GnomAD4 exome
AF:
AC:
4
AN:
241736
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
138594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000997 AC: 118AN: 118356Hom.: 12 Cov.: 18 AF XY: 0.000902 AC XY: 52AN XY: 57678
GnomAD4 genome
AF:
AC:
118
AN:
118356
Hom.:
Cov.:
18
AF XY:
AC XY:
52
AN XY:
57678
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | HLA-DQA1: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at